Allstate Corp <ALL.N>: Citigroup cuts to Sell from Neutral; raises target price to $240 from $226
ALL•Related News
Xtant Medical Q2 Revenue USD 23 Million
XTNT•
Xtant Medical Q2 revenue falls on asset sales and lost license revenue
XTNT•
C4 Therapeutics Q2 revenue beats estimates, helped by Roche collaboration
CCCC•
Fennec swings to FY26 Q2 net income of $1.97 million; net sales rise 78% to $17.1 million year over year
FENC•
CenterPoint plans $5 billion Texas customer savings initiative tied to 14 GW large-load additions over next decade
CNP•